PrEP over time: does it change risky behavior? new study investigates.
NCT ID NCT06600087
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This completed study in France looked at 248 people taking PrEP (a daily pill to prevent HIV) to see if long-term use changes risky sexual behaviors or increases sexually transmitted infections (STIs). Participants filled out a questionnaire about their sexual practices and recent STI history. The goal was to compare those on PrEP for over a year with those on it for less time, to help improve future prevention advice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux - Service de médecine interne et maladies infectieuses
Bordeaux, France
-
Cabinet de Medecine Generale
Fargues-Saint-Hilaire, France
-
Cabinet de Medecine Generale
Le Teich, France
-
Cabinet de Medecine Generale
Mérignac, France
-
Cegidd de Bordeaux
Bordeaux, France
-
Cegidd de Libourne
Libourne, France
-
Cegidd de Perigueux
Périgueux, France
-
Maison de la Santé de l'Hôpital Saint-André - Médecine Générale
Bordeaux, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better understand how PrEP use over time affects sexual behavior and STI risk, leading to improved prevention strategies.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to other regions or populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.